EGRX
Neuberger Berman Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-4,500
| Closed | -$357K | – | 1640 |
|
|
2016
Q4 | $357K | Sell |
4,500
-9,000
| -67% | -$714K | ﹤0.01% | 1364 |
|
|
2016
Q3 | $945K | Buy |
+13,500
| New | +$945K | ﹤0.01% | 1108 |
|
|
2016
Q1 | – | Sell |
-2,385
| Closed | -$211K | – | 1533 |
|
|
2015
Q4 | $211K | Sell |
2,385
-376
| -14% | -$33.3K | ﹤0.01% | 1437 |
|
|
2015
Q3 | $204K | Buy |
+2,761
| New | +$204K | ﹤0.01% | 1451 |
|